SERA - Why Is Preterm Birth Risk Kit Focused Sera Prognostics Stock Trading Higher Today? | Benzinga
Sera Prognostics Inc (NASDAQ: SERA) announced that the Data Safety Monitoring Board (DSMB) overseeing its pivotal PRIME study recommended stopping enrollment due to efficacy, reporting that either of the co-primary endpoints met the stopping criteria for statistical significance at the pre-planned interim analysis.
The company has adopted the DSMB's recommendation and ...